Neutralizing Antibody Therapeutics for COVID-19

The emergence of SARS-CoV-2 and subsequent COVID-19 pandemic has resulted in a significant global public health burden, leading to an urgent need for effective therapeutic strategies. In this article, we review the role of SARS-CoV-2 neutralizing antibodies (nAbs) in the clinical management of COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurt, Aeron C., Wheatley, Adam K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067572/
https://www.ncbi.nlm.nih.gov/pubmed/33916927
http://dx.doi.org/10.3390/v13040628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067572/
https://www.ncbi.nlm.nih.gov/pubmed/33916927
http://dx.doi.org/10.3390/v13040628

Ejemplares similares